Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-05-01FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod HCl) from Novartis Pharmaceuticals Corporation. The action indicates an …
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit [NA]
Clinical trial update reporting results of a balance training program using Nintendo Wii Fit for people with multiple sclerosis. The results…
-
CLINICAL_TRIALS research · 2015-04-21Clinical Trial Update: Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study
This is a pilot clinical trial investigating how the intensity of an intervention affects cognitive function in people with multiple scleros…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Transcranial Doppler in Multiple Sclerosis [NA]
This entry notes the completion of a clinical trial evaluating transcranial Doppler in multiple sclerosis.
-
FDA approval · 2015-04-16FDA Approved: GLATOPA — Original Application (Sandoz Inc)
The FDA approved GLATOPA (glatiramer acetate) from Sandoz as an Original Application ANDA, a generic version of Copaxone for multiple sclero…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Improving Hand Use in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update investigating methods to improve hand use in individuals with Multiple Sclerosis; current status is not disclo…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World
TYGRIS Rest of World, a global observational program evaluating the safety of TYSABRI (natalizumab) in multiple sclerosis, has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis
A multi-centre, single-blinded, controlled trial investigated the effects of exercise in people with multiple sclerosis, with the study stat…
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis [Phase 4]
Phase 4 trial update for dalfampridine ER in ambulatory activity for people with multiple sclerosis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)
This completed clinical trial update reports on costs, quality of life, and functional outcomes in veterans with multiple sclerosis treated …
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS) [NA]
This clinical trial update notes that the TakeCharge telephone-delivered self-management intervention for people with Multiple Sclerosis has…
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: A Study to Test the Use of Duloxetine for Pain in MS [Phase 2, Phase 3]
A phase 2/phase 3 clinical trial evaluating duloxetine for pain in people with multiple sclerosis has completed and posted results.
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)
Clinical trial update describing analysis of a biomarker signature in multiple sclerosis patients treated with fingolimod (Gilenya).
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI)
An update on a completed clinical trial evaluating vascular fundus changes in patients with a high probability of chronic cerebrospinal veno…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Group Balance Training for People With Multiple Sclerosis [NA]
A clinical trial evaluating group balance training for people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study [Phase 3]
The Phase 3 study evaluating cannabis extract (MUSEC) for muscle spasticity in multiple sclerosis was terminated. No efficacy results are pr…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Falls Prevention and Balance Rehabilitation in Multiple Sclerosis [NA]
The clinical trial NCT02390830 evaluating falls prevention and balance rehabilitation in people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Effects of Training on Central Auditory Function in Multiple Sclerosis [NA]
A completed clinical trial study evaluating the effects of training on central auditory function in individuals with multiple sclerosis.
-
CLINICAL_TRIALS research · 2015-03-17Clinical Trial Update: Impact of Multiple Sclerosis From the Viewpoint of the Caregivers
A clinical trial examining the perspective and experiences of caregivers of people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis [Phase 3]
A Phase 3 trial examining teriflunomide’s effect on immune cell subsets in the blood of people with multiple sclerosis has completed, provid…
-
CLINICAL_TRIALS withdrawal · 2015-03-10Clinical Trial Update: Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS) [Phase 3]
A Phase 3 trial comparing double-dose Betaferon to the approved dose in early secondary progressive multiple sclerosis has been withdrawn.
-
FDA approval · 2015-03-06FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved a supplemental application for Tecfidera (dimethyl fumarate) from Biogen Inc. The approval updates the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis [Phase 1]
This document reports the completion of a Phase 1 intravenous infusion trial of the investigational agent rHIgM22 in patients with multiple …
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Canadian Avonex PEN Productivity Study
This clinical trial update reports the completion of a Canadian study evaluating the Avonex PEN productivity in people with multiple scleros…
-
CLINICAL_TRIALS research · 2015-02-18Clinical Trial Update: Phototherapy in Persons With Multiple Sclerosis [Phase 1]
A Phase 1 clinical trial evaluating phototherapy in persons with multiple sclerosis. The study status is currently unknown.